Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.

Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ.

Ann Intern Med. 2009 Jun 16;150(12):830-9, W147-9.

PMID:
19528562
2.

Powdered red yeast rice and plant stanols and sterols to lower cholesterol.

Feuerstein JS, Bjerke WS.

J Diet Suppl. 2012 Jun;9(2):110-5. doi: 10.3109/19390211.2012.682645. Epub 2012 Apr 25.

PMID:
22531006
3.

Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.

Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G.

Adv Ther. 2011 Dec;28(12):1105-13. doi: 10.1007/s12325-011-0082-5. Epub 2011 Nov 21.

PMID:
22113535
4.

Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.

Halbert SC, French B, Gordon RY, Farrar JT, Schmitz K, Morris PB, Thompson PD, Rader DJ, Becker DJ.

Am J Cardiol. 2010 Jan 15;105(2):198-204. doi: 10.1016/j.amjcard.2009.08.672. Epub 2009 Nov 26.

PMID:
20102918
5.

The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders.

Yang CW, Mousa SA.

Complement Ther Med. 2012 Dec;20(6):466-74. doi: 10.1016/j.ctim.2012.07.004. Epub 2012 Aug 17. Review.

PMID:
23131380
6.

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement.

Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL.

Am J Clin Nutr. 1999 Feb;69(2):231-6.

7.

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.

Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, Morgan JM, Capuzzi DM; Chinese Coronary Secondary Prevention Study Group, Li S.

Am J Cardiol. 2008 Jun 15;101(12):1689-93. doi: 10.1016/j.amjcard.2008.02.056. Epub 2008 Apr 11.

PMID:
18549841
8.

Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!

Gordon RY, Cooperman T, Obermeyer W, Becker DJ.

Arch Intern Med. 2010 Oct 25;170(19):1722-7. doi: 10.1001/archinternmed.2010.382.

PMID:
20975018
9.

A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia.

Shang Q, Liu Z, Chen K, Xu H, Liu J.

Evid Based Complement Alternat Med. 2012;2012:636547. doi: 10.1155/2012/636547. Epub 2012 Apr 12.

10.

HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study.

Bogsrud MP, Ose L, Langslet G, Ottestad I, Strøm EC, Hagve TA, Retterstøl K.

Scand Cardiovasc J. 2010 Aug;44(4):197-200. doi: 10.3109/14017431003624123.

PMID:
20636227
11.

The role of red yeast rice for the physician.

Gordon RY, Becker DJ.

Curr Atheroscler Rep. 2011 Feb;13(1):73-80. doi: 10.1007/s11883-010-0145-0. Review.

PMID:
21061097
12.

An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents.

Heber D, Lembertas A, Lu QY, Bowerman S, Go VL.

J Altern Complement Med. 2001 Apr;7(2):133-9.

PMID:
11327519
13.
14.
15.

Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome.

Fujimoto M, Tsuneyama K, Chen SY, Nishida T, Chen JL, Chen YC, Fujimoto T, Imura J, Shimada Y.

Evid Based Complement Alternat Med. 2012;2012:892697. doi: 10.1155/2012/892697. Epub 2012 Dec 20.

16.

Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products.

Lapi F, Gallo E, Bernasconi S, Vietri M, Menniti-Ippolito F, Raschetti R, Gori L, Firenzuoli F, Mugelli A, Vannacci A.

Br J Clin Pharmacol. 2008 Oct;66(4):572-4. doi: 10.1111/j.1365-2125.2008.03224.x. Epub 2008 May 21. No abstract available.

17.

Lipid-lowering efficacy of red yeast rice in a population intolerant to statins.

Venero CV, Venero JV, Wortham DC, Thompson PD.

Am J Cardiol. 2010 Mar 1;105(5):664-6. doi: 10.1016/j.amjcard.2009.10.045.

PMID:
20185013
18.
19.
20.

NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements.

Lachenmeier DW, Monakhova YB, Kuballa T, Löbell-Behrends S, Maixner S, Kohl-Himmelseher M, Waldner A, Steffen C.

Chin Med. 2012 Mar 22;7:8. doi: 10.1186/1749-8546-7-8.

Supplemental Content

Support Center